Free Trial
→ Uranium Mine Flood That Sparked a 2006 Price Surge Returns (From Digest Publishing) (Ad)tc pixel Free CNSY Stock Alerts

Plus Therapeutics (CNSY) Earnings Date, Estimates & Call Transcripts

Plus Therapeutics logo
$0.95 +0.18 (+23.32%)
Closing price 04:00 PM Eastern
Extended Trading
$0.92 -0.03 (-3.28%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Plus Therapeutics Earnings Summary

Plus Therapeutics issued Q3 2026 earnings on November 13, 2026, reporting an EPS of -$1.14, which missed the consensus estimate of -$0.98 by $0.16. Quarterly revenue was reported to be $722 thousand. With a trailing EPS of -$3.36, Plus Therapeutics' earnings are expected to grow next year, from ($4.40) to ($3.17) per share.

Q3 2026 Earnings Resources

Consensus EPS
(Nov. 13)
-$0.98
Actual EPS
(Nov. 13)
-$1.14 Missed By -$0.16
Actual Revenue
(Nov. 13)
$0.72M
Get Plus Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Plus Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CNSY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CNSY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Plus Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20261-$0.98-$0.98-$0.98
Q4 20261-$0.91-$0.91-$0.91
20262-$1.89-$1.89-$1.89
Q1 20271-$0.78-$0.78-$0.78
Q2 20271-$0.78-$0.78-$0.78
Q3 20271-$0.65-$0.65-$0.65
Q4 20271-$0.66-$0.66-$0.66
FY 20274-$2.87-$2.87-$2.87

Plus Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/13/2026Q3 2026-$0.98-$1.14 -$0.16-$1.14-$0.72M
8/14/2026Q2 2026-$0.96-$1.31 -$0.35-$1.31-$0.41M

Plus Therapeutics Earnings - Frequently Asked Questions

Plus Therapeutics (NASDAQ:CNSY) last announced its quarterly earning data on Friday, August 14, 2026. Learn more on CNSY's earnings history.

In the previous quarter, Plus Therapeutics (NASDAQ:CNSY) missed the analysts' consensus estimate of ($0.96) by $0.35 with a reported earnings per share (EPS) of ($1.31). Learn more on analysts' earnings estimate vs. CNSY's actual earnings.

Plus Therapeutics (NASDAQ:CNSY) has a recorded annual revenue of $5.21 million.

Plus Therapeutics (NASDAQ:CNSY) has a recorded net income of -$22.39 million. CNSY has generated -$3.36 earnings per share over the last four quarters.

Plus Therapeutics' earnings are expected to grow from ($4.40) per share to ($3.17) per share in the next year.

Earnings Tools

Earnings data for NASDAQ:CNSY is sourced from Fiscal.ai, with the most recent quarter reported on 11/13/2026. New results are added as companies report their earnings.
From Our Partners
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel